Studies have reported that loss-of-function mutations upstream of NF-κB affect NF-κB activity in AD patients, leading to anatomical defects such as shrinkage of the entorhinal cortex and early AD limbic system [26]. This evidence concerns the gene NFKB1 and Alzheimer disease.